PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DEGENERATIVE CRANIAL NERVE DISEASES

摘要

The present invention relates to a composition for alleviating oxidative stress-induced cranial nervous system diseases, containing corn silk-derived maysin as an active ingredient and, more particularly, to a pharmacological composition for alleviating degenerative cranial nervous system diseases, wherein maysin increases the expression of mRNAs of antioxidant enzymes (catalase, glutathione peroxidase-1, superoxide dismutases 1 and 2, and heme oxygenase-1), thereby decreasing oxidative stress, and ultimately, inhibiting or blocking nerve cell apoptosis caused by oxidative stress.